CA
BLUE

Commerzbank Aktiengesellschaft’s bluebird bio BLUE Stock Holding History

Commerzbank Aktiengesellschaft’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-14,185
Closed -$311K – 938
2018
Q1 		$311K Buy
+14,185
New +$36.1M ﹤0.01% 784
2017
Q4 		– Sell
-604
Closed -$1.07M – 955
2017
Q3 		$1.07M Buy
+604
New +$844K 0.01% 454

Other funds holding BLUE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Commerzbank Aktiengesellschaft's BLUE Position: Q4 2018 in Review

Commerzbank Aktiengesellschaft sold out of bluebird bio (BLUE) in Q4 2018, closing a stake of 614 shares — an estimated $1.16M sold.

Commerzbank Aktiengesellschaft first reported a position in BLUE in Q1 2017 and held it in 7 quarters. The position peaked at $1.47M in Q4 2017. 251 funds tracked by Wall St. Rank hold BLUE as of Q4 2018.

  • Commerzbank Aktiengesellschaft reported no remaining bluebird bio position as of Q4 2018 after selling out during the quarter.
  • Commerzbank Aktiengesellschaft sold 614 bluebird bio shares in Q4 2018, an estimated $1.16M.
  • Commerzbank Aktiengesellschaft first reported a position in bluebird bio in Q1 2017 and held it in 7 quarters.
  • Commerzbank Aktiengesellschaft's bluebird bio position peaked at $1.47M in Q4 2017.
  • 251 funds tracked by Wall St. Rank held bluebird bio as of Q4 2018.

Based on Commerzbank Aktiengesellschaft's 13F filing for Q4 2018, filed 6 Feb 2019.